PIONEER joins forces with EHDEN & OHDSI for prostate cancer study-a-thon
Read moreRecent study-a-thon investigates the natural history and outcomes of prostate cancer patients managed with watchful waiting. A conservative management option for prostate cancer patients with a life expectancy of less than 10 years at time of diagnosis. The patient’s...
Uncovering the natural history of prostate cancer in data from millions of patient across the globe
Read morePIONEER, EHDEN and OHDSI join forces to study the clinical management of prostate cancer in a virtual studyathon Prostate cancer is a major disease affecting more than 2 million men in Europe alone, and has now become the most...
PIONEER Project will benefit from three new external datasets
Read morePIONEER The European Network of Excellence for Big Data in Prostate Cancer gains momentum as further Data Sharing Agreements signed with external data contributor Prof. Mauro Gacci prostate cancer research group lead at the Unit of Urological Robotic Surgery...
PIONEER virtual General Assembly Meeting Nov 2020 – join us at the halfway point of the project
Read morePIONEER convened its Annual General Assembly Meeting virtually on November 23rd and 24th, with over 60 members gathering online to report on the progress of their work packages and to exchange ideas. Discussion were focused on prioritisation of datasets...
OnFocus Podcast How Big Data Is Helping To Answer Questions About Prostate Cancer
Read moreSusan Evans Axelsson (PIONEER WP3) joins Clare Delmar from the Focal Therapy Clinic (prospective PIONEER data contributor) for OnFocus, a podcast series discussing the little known, less understood and often ignored issues facing men diagnosed with prostate cancer. For...
Calling all patients: What Outcomes are important for men with advanced prostate cancer?
Read moreCalling all patients: What Outcomes are important for men with advanced prostate cancer? An interview study Are you an advanced prostate cancer patient? Are you currently receiving, or have received in the past, either ADT or Chemotherapy treatment since...